Effert PJ, Bares R, Handt S, et al : Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. J Urol 155 : 994-998, 1996
Stewardt GD, Gray K, Pennington CJ, et al : Analysis of hypoxia-associated gene expression in prostate cancer : lysyl oxidase and glucose transporter 1 expression correlate with Gleason score. Oncol Rep 20 : 1561-1567, 2008
Shoder H, Herrmann K, Gonen M, et al : 2- [18F] fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients withprostate-specific antigen relapse after radical prostatectomy. Clin Cancer Res 11 : 4761-4769, 2005
Morris MJ, Akhurst T, Larson SM, et al : Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy. Clin Cancer Res 11 : 3210-3216, 2005